Sotatercept (mIgG2a)

Product Description: Sotatercept (mIgG2a) has direct cardioprotective actions, which reduces right ventricular (RV) remodeling and improves function in a pulmonary artery banding (PAB) mouse model[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Joshi S R, et al. Sotatercept Analog RAP-011 Inhibits Right Ventricular Remodeling and Restores Function in a Mouse Model of Pressure Overload. Circulation. 2020, 142(Suppl_3): A14397-A14397.

Molecular Weight: N/A

Compound Purity: 99.71

Research Area: Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: Others

• SKU: MEXHY-P99590A-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99590A-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated